BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 8871672)

  • 21. HLA class II influences the immune response and antibody diversification to Ro60/Sjögren's syndrome-A: heightened antibody responses and epitope spreading in mice expressing HLA-DR molecules.
    Paisansinsup T; Deshmukh US; Chowdhary VR; Luthra HS; Fu SM; David CS
    J Immunol; 2002 Jun; 168(11):5876-84. PubMed ID: 12023392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ro52, Ro60 and La IgG autoantibody levels and Ro52 IgG subclass profiles longitudinally throughout pregnancy in congenital heart block risk pregnancies.
    Strandberg L; Salomonsson S; Bremme K; Sonesson S; Wahren-Herlenius M
    Lupus; 2006; 15(6):346-53. PubMed ID: 16830880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 52-kDa Ro/SSA epitopes preferentially recognized by antibodies from mothers of children with neonatal lupus and congenital heart block.
    Fritsch C; Hoebeke J; Dali H; Ricchiuti V; Isenberg DA; Meyer O; Muller S
    Arthritis Res Ther; 2006; 8(1):R4. PubMed ID: 16356190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hierarchical self-tolerance to T cell determinants within the ubiquitous nuclear self-antigen La (SS-B) permits induction of systemic autoimmunity in normal mice.
    Reynolds P; Gordon TP; Purcell AW; Jackson DC; McCluskey J
    J Exp Med; 1996 Nov; 184(5):1857-70. PubMed ID: 8920873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calreticulin binds preferentially with B cell linear epitopes of Ro60 kD autoantigen, enhancing recognition by anti-Ro60 kD autoantibodies.
    Staikou EV; Routsias JG; Makri AA; Terzoglou A; Sakarellos-Daitsiotis M; Sakarellos C; Panayotou G; Moutsopoulos HM; Tzioufas AG
    Clin Exp Immunol; 2003 Oct; 134(1):143-50. PubMed ID: 12974767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-ENA profiles related with anti-SS-A/Ro. The detection of Ro52 and Ro60 according to the presence of SS-B/La, and ANA pattern and titer.
    González DA; Rodríguez CC; Armas LM; Varela AR; Rodríguez IM; Duarte MT; de León AC
    Immunol Lett; 2014 Sep; 161(1):6-12. PubMed ID: 24768604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic Utility of Separate Anti-Ro60 and Anti-Ro52/TRIM21 Antibody Detection in Autoimmune Diseases.
    Robbins A; Hentzien M; Toquet S; Didier K; Servettaz A; Pham BN; Giusti D
    Front Immunol; 2019; 10():444. PubMed ID: 30915082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunization with peptides from 60 kDa Ro in diverse mouse strains.
    Scofield RH; Pierce PG; James JA; Kaufman KM; Kurien BT
    Scand J Immunol; 2002 Nov; 56(5):477-83. PubMed ID: 12410797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytoplasmic accumulation of the 52 kDa Ro/SS-A nuclear autoantigen in transfected cell lines.
    Keech CL; Gordon TP; McCluskey J
    J Autoimmun; 1995 Oct; 8(5):699-712. PubMed ID: 8579725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determinant spreading: lessons from animal models and human disease.
    McCluskey J; Farris AD; Keech CL; Purcell AW; Rischmueller M; Kinoshita G; Reynolds P; Gordon TP
    Immunol Rev; 1998 Aug; 164():209-29. PubMed ID: 9795778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The value of separate detection of anti-Ro52, anti-Ro60 and anti-SSB/La reactivities in relation to diagnosis and phenotypes in primary Sjögren's syndrome.
    Deroo L; Achten H; De Boeck K; Genbrugge E; Bauters W; Roels D; Dochy F; Creytens D; Deprez J; Van den Bosch F; Elewaut D; Peene I
    Clin Exp Rheumatol; 2022 Dec; 40(12):2310-1317. PubMed ID: 36200940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoantibody responses to the "native" 52-kDa SS-A/Ro protein in neonatal lupus syndromes, systemic lupus erythematosus, and Sjogren's syndrome.
    Buyon JP; Slade SG; Reveille JD; Hamel JC; Chan EK
    J Immunol; 1994 Apr; 152(7):3675-84. PubMed ID: 7511655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subcellular redistribution and surface exposure of the Ro52, Ro60 and La48 autoantigens during apoptosis in human ductal epithelial cells: a possible mechanism in the pathogenesis of Sjögren's syndrome.
    Ohlsson M; Jonsson R; Brokstad KA
    Scand J Immunol; 2002 Nov; 56(5):456-69. PubMed ID: 12410795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antibodies against recombinant Ro 60 Kd, Ro 52 and La 48 Kd proteins in primary Sjogren's Syndrome. Utility of analytic methods combination to detect antibodies anti Ro and La].
    Aguilera S; González MJ; Pérez P; Castillo D; Gatica H
    Rev Med Chil; 2002 Aug; 130(8):841-9. PubMed ID: 12360791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fine specificity of the Ro/SSA autoantibody response in relation to serological and clinical findings in 96 patients with self-reported cutaneous symptoms induced by the sun.
    Popovic K; Brauner S; Ek M; Wahren-Herlenius M; Nyberg F
    Lupus; 2007; 16(1):10-7. PubMed ID: 17283579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of microRNAs (miRNAs) that are predicted to target the autoantigens Ro/SSA and La/SSB in primary Sjögren's Syndrome.
    Gourzi VC; Kapsogeorgou EK; Kyriakidis NC; Tzioufas AG
    Clin Exp Immunol; 2015 Oct; 182(1):14-22. PubMed ID: 26201309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accessibility of epitopes on the 52-kD Ro/SSA protein (Ro52) and on the RoRNP associated Ro52 protein as determined by anti-peptide antibodies.
    Ricchiuti V; Pruijn GJ; Thijssen JP; van Venrooij WJ; Muller S
    J Autoimmun; 1997 Apr; 10(2):181-91. PubMed ID: 9185880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The development of a quantitative assay for the detection of anti-Ro/SS-A and anti-LA/SS-B autoantibodies using purified recombinant proteins.
    Veldhoven CH; Meilof JF; Huisman JG; Smeenk RJ
    J Immunol Methods; 1992 Jul; 151(1-2):177-89. PubMed ID: 1629608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical associations of the positive anti Ro52 without Ro60 autoantibodies: undifferentiated connective tissue diseases.
    Murng SHK; Thomas M
    J Clin Pathol; 2018 Jan; 71(1):12-19. PubMed ID: 28663326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-translational modifications of the major linear epitope 169-190aa of Ro60 kDa autoantigen alter the autoantibody binding.
    Terzoglou AG; Routsias JG; Moutsopoulos HM; Tzioufas AG
    Clin Exp Immunol; 2006 Oct; 146(1):60-5. PubMed ID: 16968399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.